Century Therapeutics

IPSC48

Penny Stock

$1.35arrow_drop_up3.07%$0.04

Penny Stock

IPSC48

$1.35

arrow_drop_up3.07%$0.04

Penny Stock

Performance History

Key Stats
Open	$1.34
Prev. Close	$1.30
EPS	-1.83
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$114.78M
PE Ratio	-

	LOW	HIGH
Day Range	1.30	1.37
52 Week Range	1.15	5.51

Ratios







EPS	-1.83

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Century Therapeutics (IPSC)

IPSC is a publicly-traded company on the stock exchange. The history of IPSC's stock price shows a pattern of fluctuation over the years. The price has experienced both highs and lows, influenced by various factors such as market trends, company performance, and investor sentiment. It is important for potential investors to analyze the stock price history to make informed decisions. The current quote for IPSC reflects the most recent trading price of the stock. This quote is updated regularly to provide real-time information to investors. It is essential for investors to stay updated with the latest stock quotes to track the performance of IPSC.

The stock market is constantly evolving, and staying informed about the latest news related to IPSC is crucial for investors. News articles often provide insights into the company's financial performance, market trends, and other relevant information. It is recommended to follow reputable sources for accurate and reliable news updates. In addition to news articles, investors can also benefit from stock analysis reports. These reports provide a detailed evaluation of IPSC's financial health, competitive position, and growth prospects. By analyzing these reports, investors can gain a deeper understanding of IPSC's potential as an investment.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Gregory Russotti Ph.D.
Headquarters: Philadelphia
Employees: 163
Exchange: NASDAQ

Keep an eye on Century Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Century Therapeutics 's (IPSC) price per share?

The current price per share for Century Therapeutics (IPSC) is $1.35. The stock has seen a price change of $0.04 recently, indicating a 3.08% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Century Therapeutics (IPSC)?

For Century Therapeutics (IPSC), the 52-week high is $5.51, which is 308.15% from the current price. The 52-week low is $1.15, the current price is 17.29% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Century Therapeutics (IPSC) a growth stock?

Century Therapeutics (IPSC) has shown an average price growth of -3.4% over the past three years. It has received a score of 6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Century Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Century Therapeutics (IPSC) stock price performance year to date (YTD)?

As of the latest data, Century Therapeutics (IPSC) has a year-to-date price change of -62.91%. Over the past month, the stock has experienced a price change of -2.88%. Over the last three months, the change has been -33.17%. Over the past six months, the figure is -59.09%.

help

Is Century Therapeutics (IPSC) a profitable company?

Century Therapeutics (IPSC) has a net income of -$136.67M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -4.4K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $2.24M, although specific revenue growth data is currently not available. Operating income is noted at -$146.55M. Furthermore, the EBITDA is -$117.93M.

help

What is the market capitalization of Century Therapeutics (IPSC)?

Century Therapeutics (IPSC) has a market capitalization of $114.79M. The average daily trading volume is 1.34, indicating the stock's liquidity and investor engagement.

News

CENTURY THERAPEUTICS

LEADERSHIP TEAM

CHIEF FINANCIAL OFFICER

CHIEF SCIENTIFIC OFFICER

Sep 26, 2024

Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer

TARGETED THERAPEUTICS

Targeted Therapeutics Market is Pioneering Growth Towards a USD 118.6 Billion Milestone by 2031, with a CAGR of 6.4% - Exclusive Report by Transparency Market Research, Inc.

ANALYST RATINGS

Jun 4, 2024

5 Analysts Assess Century Therapeutics: What You Need To Know

HEALTH

PRODUCT / SERVICES ANNOUNCEMENT

RESEARCH ANALYSIS AND REPORTS

Jun 3, 2024

Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting

May 9, 2024

Century Therapeutics, Inc. (IPSC) Reports Q1 Loss, Tops Revenue Estimates

CALENDAR OF EVENTS

Apr 23, 2024